Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Mylan Pharmaceuticals Inc
- 1500 Corporate Dr. Canonsburg, Pa. 15317 Key contact: HARRY KORMAN, President Phone: (724)-514-1800 Fax: 724-514-1870 www.mylan.com CANONSBURG, Pa. -- Mylan Laboratories Inc. is one of the world's leading generics and speciality pharmaceutical companies. As one of the generics industry's pioneers, Mylan has remained...
- Research articles 2007-09-17
- Mylan Announces the U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate ANDAs.
- M2 PRESSWIRE-27 March 2007-Afternoon Movers: Mylan Announces the U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate ANDAsC1994-2007 M2 COMMUNICATIONS LTD RDATE:27032007 Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay...
- Research articles 2007-03-27
- MARKET ALERTS: "HEE Corporation -- Clinical Trial at a Major University"
- eLocity's velocity stocks to watch for today are: HEE Corporation (OTC: HCCF), Aastrom Biosciences, Inc. (NASDAQ: ASTM), Biopure Corporation (NASDAQ: BPUR), Mylan Laboratories Inc. (NYSE: MYL) Investors will surely want to keep an eye on HEE Corporation (OTC: HCCF). HEE Corporation announced after the closing bell on Tuesday that...
- Research articles 2004-11-03
- Mylan Pharmaceuticals Inc
- 781 Chestnut Ridge Rd. Morgantown, W. Va. 26505-4310 Phone: (304) 599-2595 Fax: (304) 598-3232 Web site: mylan.com; mylanpharms.com Key contact: Jason Harper, associate director of marketing MORGANTOWN, W.Va. -- Mylan Pharmaceuticals Inc.'s parent company Mylan Laboratories Inc. announced financial results for the first quarter ended June...
- Research articles 2003-09-29
- Omeprazole. (Pharma in Brief).(Mylan Pharmaceuticals launches delayed release capsules)(Brief Article)
- OMEPRAZOLE Mylan Laboratories Inc., through its wholly owned subsidiary Mylan Pharmaceuticals Inc., has launched 10 mg and 20 mg omeprazole delayed release capsules. The drug is the generic version of AstraZeneca PLC's Prilosec.
- Research articles 2003-08-11
- Cambrex stock crashes on major profit warning; Mylan settlement adds to woes: 2003 EPS forecast revised to $1.05 to $1.25 versus $2 to $2.15. (Financial).
- NOT LONG AGO a darling of Wall Street, Cambrex Corp. saw its shares plunge by more than one-third as it dramatically slashed 2003 profit projections in the face of the loss of a major contract biopharmaceutical manufacturing customer, a tentative legal settlement with Mylan Laboratories Inc.,...
- Research articles 2003-04-14
- Pittsburgh Post-Gazette Business Briefs Column.
- Pittsburgh Post-Gazette Knight Ridder/Tribune Business News Dec. 21--CONCERN TO END EPHEDRA OUTPUT: A Florida maker of weight management products will discontinue all those containing ephedra because a supplier has been unable to get liability insurance for such products. Health &...
- Research articles 2002-12-21
- Mylan Pharmaceuticals Inc
- 781 Chestnut Ridge Rd. Morgantown, W.Va. 26505-4310 Phone: (304) 599-2595 (800) 796-9526 Fax: (304) 598-3232 Web site: mylan.com; mylanpharms.com MORGANTOWN, W.Va. -- Life at 40 is proving to be a busy time for Mylan Pharmaceuticals Inc. A year after celebrating the completion of...
- Research articles 2002-09-30
- Robert J.Coury.(Newsmakers)
- * Mylan Laboratories Inc. named Robert J. Coury chief executive officer. Coury has been serving as a consultant to Mylan since 1995. He has already been appointed ... * Mylan Laboratories Inc. named Robert J. Coury chief executive officer. Coury has been serving as a consultant...
- Research articles 2003-06-01
- Spencer Stuart/Directors & Boards Directors Roster. (H-Z).
- HAGGAR CORP. 6113 Lemmon Avenue, Dallas, TX 75209 has added to its board: Donald E. Godwin Chairman and CEO GODWIN GRUBER PC 1201 Elm Street, Suite 1700, Dallas, TX 75270 ...
- Research articles 2002-06-22
- Mylan Reports Record Revenues and Earnings For The Fourth Quarter and Fiscal 2002
- Business Editors PITTSBURGH--BUSINESS WIRE--May 8, 2002 Mylan Laboratories Inc.(NYSE: MYL)- Financial Highlights: - Net revenues increased 30% to exceed $1.1 billion for the fiscal year and 14% to $282.6 million for the quarter. - Gross profit increased 63% to $623.9 million for the fiscal year and...
- Research articles 2002-05-08
- Spencer Stuart/Directors & Boards Directors Roster.
- 1-800-ATTORNEY INC. 186 Attorneys.com Court Lake Helen, FL 32744 has added to its board: George R. Boltres Jr. Partner TIEDEMANN INVESTMENT GROUP 535 Madison Avenue, 37th Floor New York, NY 10022 ...
- Research articles 2002-03-22
- Mylan Laboratories Announces First Quarter Fiscal 2002 Financial Results
- Business Editors PITTSBURGH--BUSINESS WIRE--July 25, 2001 Mylan Laboratories, Inc. (NYSE: MYL) today reported financial results for the first quarter ended June 30, 2001. Net earnings were $50.6 million or $.40 per diluted share compared to $18.0 million or $.14 per diluted share, excluding the impact of the...
- Research articles 2001-07-25
- Pittsburgh Post-Gazette Business Briefs Column.
- Pittsburgh Post-Gazette Knight Ridder/Tribune Business News Jun. 29--MYLAN: 'WE'RE ARE NOT FOR SALE': A disclosure tucked into Mylan Laboratories Inc.'s annual filing with the Securities and Exchange Commission convinced one analyst that the Pittsburgh drug maker might be looking for a buyer. But a...
- Research articles 2001-06-29
- Mylan Laboratories Announces Third Quarter 2001 Results
- Business/Medical Editors PITTSBURGH, Pa.--BUSINESS WIRE--Jan. 30, 2001 Mylan Laboratories Inc. (NYSE:MYL) today reported financial results for the third quarter of fiscal 2001, ended December 31, 2000. Net sales for the quarter were $223.2 million compared to net sales of $203.9 million for the comparable quarter in fiscal 2000....
- Research articles 2001-01-30
- Mylan Declares Regular Quarterly Dividend
- Business Editors PITTSBURGH--BUSINESS WIRE--December 15, 2000 Mylan Laboratories Inc. (NYSE:MYL) announced today that the regular quarterly cash dividend of four cents per share will be paid on January 15, 2001 to shareholders of record December 31, 2000.
- Research articles 2000-12-15
- Pittsburgh Generic Drug Firm, Executives Give 60,000 to West Virginia Governor.(Knight Ridder/Tribune Business News)
- Oct. 23--Milan Puskar and other executive officers and spouses from Mylan Pharmaceuticals have already given $60,000 to Gov. Cecil Underwood during this year's primary and general election campaigns. Puskar and Mylan employees are, by far, the largest single group of contributors to any West...
- Research articles 2000-10-23
- Mylan Declares Regular Quarterly Dividend
- Business Editors PITTSBURGH--BUSINESS WIRE--Sept. 14, 2000 Mylan Laboratories Inc. (NYSE:MYL) announced today that the regular quarterly cash dividend of four cents per share will be paid on October 15, 2000 to shareholders of record September 30, 2000.
- Research articles 2000-09-14
- Mylan Declares Regular Quarterly Dividend
- Business Editors PITTSBURGH--BUSINESS WIRE--June 16, 2000 Mylan Laboratories Inc. (NYSE:MYL) Announced today that the regular quarterly cash dividend of four cents per share will be paid on July 15, 2000 to shareholders of record June 30, 2000.
- Research articles 2000-06-16
- Mylan wins FDA approval for generic Accutane. (Markets: Life Sciences).(Brief Article)
- MYLAN LABORATORIES Inc. has received Food and Drug Administration FDA approval for its generic version of Roche's acne drug Accutane/Roaccutan isotretinoin. Mylan's branded subsidiary Bertek Pharmaceuticals Inc. will market isotretinoin u MYLAN LABORATORIES Inc. has received Food and...
- Research articles 2002-11-18
- << Previous
- page 1 of 5
- Next >>
Refining Tags
- Business Wire (30 results)
- FINANCE (25 results)
- Pittsburgh (12 results)
- dividend (12 results)
- FTC (11 results)
- Government (9 results)
- Tablets (8 results)
- HARDWARE (8 results)
- FDA (7 results)
- sales (7 results)
- settlement (6 results)
- Notebooks (6 results)
- earnings (6 results)
- stock (5 results)
- Litigation (5 results)
- Investment (4 results)
- Company (4 results)
- MARKETING (4 results)
- Mylan Pharmaceuticals Inc. (4 results)
- revenue (3 results)
- equity (3 results)
- TIAA-CREF (3 results)
